Capricor Therapeutics CAPR Change in Accrued Liabilities
Change in Accrued Liabilities at other companies
Other financials
Where this comes from
Reported directly by Capricor Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities.
The official record: Capricor Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Capricor Therapeutics's change in accrued liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Capricor Therapeutics's change in accrued liabilities?
- Capricor Therapeutics (CAPR) reported change in accrued liabilities of -$3.08M in Q1 2026.
- How has Capricor Therapeutics's change in accrued liabilities changed year-over-year?
- Capricor Therapeutics's change in accrued liabilities decreased by 334.3% year-over-year, from $1.32M to -$3.08M.
- What does change in accrued liabilities mean?
- Change in accrued expenses and other current liabilities, reflecting timing differences between expense recognition and cash payment.